Vemurafenib and cutaneous adverse events - report of five cases

• Main Authors: Giselle de Barros Silva (Author), Adriana Pessoa Mendes (Author), Mariana Petaccia de Macedo (Author), Clóvis Antônio Lopes Pinto (Author), Ivana Lameiras Gibbons (Author), João Pedreira Duprat Neto (Author)
• Format: Book
• Published: Sociedade Brasileira de Dermatologia, 2015-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

AbstractVemurafenib is a selective inhibitor of V600E-mutant BRAF protein used to treat metastatic and unresectable melanoma. Clinical trials have shown increased overall survival and progression-free survival in patients treated with Vemurafenib. However, cutaneous adverse events are common during...